Oxford vaccine chief says UK is at risk of being overwhelmed by virus


  • English
  • Arabic

UK hospitals are on the verge of being overwhelmed but vaccines provide a spark of hope, the head of the Oxford Vaccine Group said on Monday.

Prof Andrew Pollard made the remarks after becoming the third person in the world to receive the Oxford/AstraZeneca vaccine outside trial conditions.

Six hospitals in England will this week administer the first of about 530,000 doses Britain has currently.

The drug will arrive at hundreds of sites in the coming days and the government hopes to deliver tens of millions of doses within months, provided AstraZeneca can increase supply.

Prof Pollard said the vaccine was being distributed at a critical moment for the country. "We are at the point of being overwhelmed by this disease," he told BBC Breakfast.

The UK has ordered about 100 million doses of the Oxford/AstraZeneca vaccine – enough to immunise 50 million people with the two shots required.

Last month, Britain became the first country to use the vaccine produced by Pfizer and BioNTech, which has to be stored at ultra-low temperatures.

The Oxford/AstraZeneca vaccine is considered easier to distribute as it can be kept in a normal fridge, and costs less than $5 a dose.

Professor Andrew Pollard, director of the Oxford Vaccine Group, receives his shot on Monday. AP
Professor Andrew Pollard, director of the Oxford Vaccine Group, receives his shot on Monday. AP

It was also developed in record time, taking less than 12 months from conception to approval, a process that typically takes five to 10 years.

Regulators say the vaccine is on average 70 per cent effective in protecting against Covid-19 when taken as two full doses eight to 12 weeks apart.

“So far the evidence indicates there shouldn’t be a problem against this new variant,” Prof Pollard told Sky News when asked of its efficacy against the more infectious variant.

Prof Pollard, a paediatrician, received the shot because health workers are prioritised under the UK government’s staggered vaccination programme.

He assured people the shot was safe and urged people to take it when they are called.

“We are only going to make an impact when vaccines are in people’s arms,” he said. “They do nothing in the glass vial.”

  • 82-year-old Brian Pinker receives the Oxford University/AstraZeneca vaccine from nurse Sam Foster at the Churchill Hospital in Oxford. AP Photo
    82-year-old Brian Pinker receives the Oxford University/AstraZeneca vaccine from nurse Sam Foster at the Churchill Hospital in Oxford. AP Photo
  • 88-year-old Trevor Cowlett receives the Oxford University/AstraZeneca vaccine at the Churchill Hospital in Oxford. AP Photo
    88-year-old Trevor Cowlett receives the Oxford University/AstraZeneca vaccine at the Churchill Hospital in Oxford. AP Photo
  • Professor Andrew Pollard, Director of the Oxford Vaccine Group, receives the Oxford University/AstraZeneca vaccine from nurse Sam Foster, at the Churchill Hospital in Oxford. AP Photo
    Professor Andrew Pollard, Director of the Oxford Vaccine Group, receives the Oxford University/AstraZeneca vaccine from nurse Sam Foster, at the Churchill Hospital in Oxford. AP Photo
  • Prime Minister Boris Johnson has his temperature checked during a visit to Chase Farm Hospital on the day that the NHS ramps up its vaccination programme. Getty Images
    Prime Minister Boris Johnson has his temperature checked during a visit to Chase Farm Hospital on the day that the NHS ramps up its vaccination programme. Getty Images
  • Chief nurse nurse Sam Foster holds a vial of the Oxford University/AstraZeneca vaccine, at the Churchill Hospital in Oxford. AP Photo
    Chief nurse nurse Sam Foster holds a vial of the Oxford University/AstraZeneca vaccine, at the Churchill Hospital in Oxford. AP Photo
  • Assistant Technical Officer Lukasz Najdrowski handles doses of the Oxford University/AstraZeneca vaccine as they arrive at the Princess Royal Hospital in Haywards Heath. Reuters
    Assistant Technical Officer Lukasz Najdrowski handles doses of the Oxford University/AstraZeneca vaccine as they arrive at the Princess Royal Hospital in Haywards Heath. Reuters
  • Doses of the Oxford University/AstraZeneca vaccine arrive at the Princess Royal Hospital in Haywards Heath. Getty Images
    Doses of the Oxford University/AstraZeneca vaccine arrive at the Princess Royal Hospital in Haywards Heath. Getty Images
  • Assistant Technical Officer Lukasz Najdrowski unpacks doses of the Oxford University/AstraZeneca vaccine. Getty Images
    Assistant Technical Officer Lukasz Najdrowski unpacks doses of the Oxford University/AstraZeneca vaccine. Getty Images
  • The Princess Royal Hospital in Haywards Heath, West Sussex, where doses of the Oxford University/AstraZeneca were delivered today. Getty Images
    The Princess Royal Hospital in Haywards Heath, West Sussex, where doses of the Oxford University/AstraZeneca were delivered today. Getty Images
The candidates

Dr Ayham Ammora, scientist and business executive

Ali Azeem, business leader

Tony Booth, professor of education

Lord Browne, former BP chief executive

Dr Mohamed El-Erian, economist

Professor Wyn Evans, astrophysicist

Dr Mark Mann, scientist

Gina MIller, anti-Brexit campaigner

Lord Smith, former Cabinet minister

Sandi Toksvig, broadcaster

 

Ten tax points to be aware of in 2026

1. Domestic VAT refund amendments: request your refund within five years

If a business does not apply for the refund on time, they lose their credit.

2. E-invoicing in the UAE

Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption. 

3. More tax audits

Tax authorities are increasingly using data already available across multiple filings to identify audit risks. 

4. More beneficial VAT and excise tax penalty regime

Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.

5. Greater emphasis on statutory audit

There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.

6. Further transfer pricing enforcement

Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes. 

7. Limited time periods for audits

Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion. 

8. Pillar 2 implementation 

Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.

9. Reduced compliance obligations for imported goods and services

Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations. 

10. Substance and CbC reporting focus

Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity. 

Contributed by Thomas Vanhee and Hend Rashwan, Aurifer

PSA DUBAI WORLD SERIES FINALS LINE-UP

Men’s: 
Mohamed El Shorbagy (EGY)
Ali Farag (EGY)
Simon Rosner (GER)
Tarek Momen (EGY)
Miguel Angel Rodriguez (COL)
Gregory Gaultier (FRA)
Karim Abdel Gawad (EGY)
Nick Matthew (ENG)

Women's: 
Nour El Sherbini (EGY)
Raneem El Welily (EGY)
Nour El Tayeb (EGY)
Laura Massaro (ENG)
Joelle King (NZE)
Camille Serme (FRA)
Nouran Gohar (EGY)
Sarah-Jane Perry (ENG)

THE%20STRANGERS'%20CASE
%3Cp%3E%3Cstrong%3EDirector%3C%2Fstrong%3E%3A%20Brandt%20Andersen%3Cbr%3E%3Cstrong%3EStarring%3A%20%3C%2Fstrong%3EOmar%20Sy%2C%20Jason%20Beghe%2C%20Angeliki%20Papoulia%3Cbr%3E%3Cstrong%3ERating%3A%3C%2Fstrong%3E%204%2F5%3C%2Fp%3E%0A
PAKISTAN v SRI LANKA

Twenty20 International series
Thu Oct 26, 1st T20I, Abu Dhabi
Fri Oct 27, 2nd T20I, Abu Dhabi
Sun Oct 29, 3rd T20I, Lahore

Tickets are available at www.q-tickets.com

The specs

Engine: 4.0-litre, six-cylinder

Transmission: six-speed manual

Power: 395bhp

Torque: 420Nm

Price: from Dh321,200

On sale: now